# US 2011/0300556 A1 · Monoclonal antibodies detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid in plants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0300556 A1
- Document ID: US20110300556A1
- Status: Published application
- Kind: A1
- Application number: 13/151,389
- Filed: 2011-06-02
- Published: 2011-12-08
- Earliest claimed: 2010-06-04
- Assignees: Dow AgroSciences LLC
- Inventors: Guomin Shan; Gaofeng Lin; Joelene K. Smith Drake; Marcelo Sosa
- Web page: https://patentgrep.com/patent/US20110300556A1

## CPC

- G01N 33/573: for enzymes or isoenzymes
- C07K 16/40: against enzymes
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Described herein are monoclonal antibodies and methods useful for determining and quantitating the presence of an aryloxyalkanoate dioxygenase enzyme.

## Claims

### Claim 1

A monoclonal antibody that specifically binds to an aryloxyalkanoate dioxygenase enzyme (AAD-12) selected from the group of antibodies consisting of 539B181.2, 539B470.2, 539B489.2, 539B304.2, and 539B478.2.

### Claim 2 (depends on 1)

The monoclonal antibody of claim 1 produced by the hybridoma having a designation of 539B181.2.

### Claim 3 (depends on 1)

The monoclonal antibody of claim 1 produced by the hybridoma having a designation of 539B470.2.

### Claim 4 (depends on 1)

The monoclonal antibody of claim 1 produced by the hybridoma having a designation of 539B498.2.

### Claim 5 (depends on 1)

The monoclonal antibody of claim 1 produced by the hybridoma having a designation of 539B304.2.

### Claim 6 (depends on 1)

The monoclonal antibody of claim 1 produced by the hybridoma having a designation of 539B478.2.

### Claim 7 (depends on 1)

A hybridoma cell line that produces a monoclonal antibody of claim 1 that is on deposit with the American Type Culture Collection (ATCC) under Accession Numbers selected from the group consisting of PTA-10919, PTA-10920, PTA-10921, PTA-10922, and PTA-10923.

### Claim 8 (depends on 7)

The hybridoma of claim 7 deposited under ATCC Accession Number PTA-10919.

### Claim 9 (depends on 7)

The hybridoma of claim 7 deposited under ATCC Accession Number PTA-10920.

### Claim 10 (depends on 7)

The hybridoma of claim 7 deposited under ATCC Accession Number PTA-10921.

### Claim 11 (depends on 7)

The hybridoma of claim 7 deposited under ATCC Accession Number PTA-10922.

### Claim 12 (depends on 7)

The hybridoma of claim 7 deposited under ATCC Accession Number PTA-10923.

### Claim 13 (depends on 1)

A method for identifying the presence of an AAD-12 enzyme comprising:
a) immobilizing a first monoclonal antibody of claim 1 onto an assay surface then washing said assay surface;
b) contacting said assay surface with a liquid suspected of containing AAD-12 for a period of time sufficient to allow binding then washing said assay surface;
c) contacting said assay surface with a different second antibody of claim 1 conjugated to a reporting group for a period of time sufficient to allow binding of said second conjugated monoclonal antibody then washing said assay surface; and,
d) detecting the presence or absence of said reporting group.

### Claim 14 (depends on 1)

A method for the quantitative determination of an AAD-12 enzyme comprising:
a) immobilizing an AAD-12 antiserum onto an assay surface;
b) contacting said assay surface with a liquid suspected of containing AAD-12 for a period of time sufficient to allow binding then washing said assay surface;
c) contacting said assay surface with a different second antibody of claim 1 conjugated to a reporting group for a period of time sufficient to allow binding of said second conjugated monoclonal antibody then washing said assay surface; and,
d) quantitating the presence of said reporting group by comparison to a calibration curve.

### Claim 15 (depends on 14)

The method of claim 14 wherein the conjugated monoclonal antibody is 539B470.2.
